Product Information
ESCITALOPRAM 10 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0398 per EA under NDC 16729016917. Its NADAC has been published 649 times since Dec 18, 2013.
FDA first approved this application on Sep 11, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729016917
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA202389FDA Approved
9/11/2012
TE Code
AB
On Market Since
3/19/2013
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 10 MG TABLET has been published 649 times since Dec 18, 2013, and over the history we have for it it has declined 72.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0398 per EA |
|---|---|
| All-time high | $0.1617 (Aug 12, 2015) |
| All-time low | $0.0345 (Nov 20, 2024) |
| 52-week high | $0.0446 |
| 52-week low | $0.0398 |
| Median price | $0.0627 |
| Average price | $0.0741 |
| Largest weekly change | +37.7% (Mar 23, 2016) |
| Weeks tracked | 649 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.3%
1Y
-10.8%
3Y
-20.4%
5Y
-33.6%
All
-72.1%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 10 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0398 per EA (NDC 16729016917), effective May 20, 2026.
How has the price of ESCITALOPRAM 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 10 MG TABLET has declined 72.1%. It has been tracked across 649 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 10 MG TABLET?
Since Dec 18, 2013, the NADAC for ESCITALOPRAM 10 MG TABLET has ranged from a low of $0.0345 (Nov 20, 2024) to a high of $0.1617 (Aug 12, 2015), with a median of $0.0627 per EA.
Are there cheaper alternatives to ESCITALOPRAM 10 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ESCITALOPRAM 10 MG TABLET, is $0.0394 per EA — about 1% below ESCITALOPRAM 10 MG TABLET.
Who manufactures ESCITALOPRAM 10 MG TABLET?
ESCITALOPRAM 10 MG TABLET (NDC 16729016917) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.